市场调查报告书
商品编码
1541345
2024-2032 年营养基因组学市场报告(按产品、样本类型、应用、最终用户和地区)Nutrigenomics Market Report by Product, Sample Type, Application, End User, and Region 2024-2032 |
IMARC Group年,全球营养基因组市场规模达到12.126亿美元。
营养基因组学,也称为营养基因组学,是分析营养、健康和人类基因组之间关係的医学子集。它的重点是了解基因和饮食之间的相关性及其对人体健康的影响以及癌症、心血管疾病 (CVD) 和肥胖等疾病的风险。营养基因组学有助于检测老化和疾病易感因素,并根据基因型製定个人化饮食或营养计划。它还有助于了解大量营养素和微量营养素的毒性和安全性,并有助于预防与饮食相关的疾病。除此之外,营养基因组学测试通常透过采集血液、口腔拭子和唾液样本来完成。
全球肥胖盛行率不断上升,为市场创造了积极的前景。营养基因组学有助于了解个体基因水平,根据该水平给予适当的营养饮食,进一步减少肥胖。此外,消费者对健康和健身的兴趣不断增长,以及对个人化营养产品的需求不断增加,特别是运动员和健身爱好者,有利于市场的成长。除此之外,主要参与者正在广泛投资于研发(R&D)活动,以利用人类遗传学作为发现的基础来引入创新药物和潜在疗法。他们还专注于开发客製化食品来匹配特定的基因特征,例如增强薄弱的免疫系统和减少胆固醇化合物的摄取量,这反过来又促进了市场的成长。此外,营养缺乏症的发生率不断增加,例如缺乏维生素D 和K、叶酸、铁性贫血、低血钙、骨软化症、干眼症、坏血病、糙皮病和佝偻病,也是另一种生长诱导因子。除此之外,大众健康意识的提高,营养食品的消费增加以降低心臟病、糖尿病和其他慢性病的风险,以及对营养基因组测试的好处的认识不断增强,预计将推动市场成长。
The global nutrigenomics market size reached US$ 1,212.6 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 3,049.7 Million by 2032, exhibiting a growth rate (CAGR) of 10.47% during 2024-2032.
Nutrigenomics, also known as nutritional genomics, is a subset of medical science that analyzes the relationship between nutrition, health, and the human genome. It focuses on understanding the correlation between genes and diet and their effect on a person's health and the risk of developing diseases, such as cancer, cardiovascular diseases (CVDs), and obesity. Nutrigenomics helps detect factors of aging and disease predisposition and create personalized diet or nutrition plans depending on genotype. It also assists in understanding the toxicity and safety profile of macro- and micronutrients and preventing diet-associated diseases. Besides this, nutrigenomics testing is commonly done by taking samples of blood, buccal swabs, and saliva.
The rising prevalence of obesity across the globe is creating a positive outlook for the market. Nutrigenomics helps understand the individual gene level, according to which a proper nutrition diet is given, further resulting in decreased obesity. Additionally, the growing consumer inclination toward health and fitness and the increasing demand for personalized nutrition products, especially among athletes and fitness enthusiasts, is favoring the market growth. Apart from this, key players are extensively investing in research and development (R&D) activities to introduce innovative medicine and potential cures using human genetics as a basis for discovery. They are also focusing on developing tailor-made food to match a particular gene profile, such as strengthening the weak immune system and decreasing the intake of cholesterol compounds, which, in turn, is facilitating the market growth. Moreover, the increasing incidences of nutritional deficiency disorders, such as lack of vitamins D and K, folate, iron anemia, hypocalcemia, osteomalacia, xerophthalmia, scurvy, pellagra, and rickets, are acting as another growth-inducing factor. Besides this, the rising health consciousness among the masses, increasing consumption of nutritious food to mitigate risks of heart diseases, diabetes, and other chronic diseases, and growing awareness about the benefits of nutrigenomic testing are anticipated to drive the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global nutrigenomics market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, sample type, application and end user.
Reagents and Kits
Services
Saliva
Buccal Swab
Blood
Others
Cardiovascular Diseases
Obesity
Cancer Research
Others
Dieticians
Sport Clinics
Corporate Programs
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being BASF SE, Cell-Logic, Cura Integrative Medicine, Danone S.A, Fagron, Genova Diagnostics, Holistic Health International, Koninklijke DSM N.V., Metagenics Inc., Nutrigenomix Inc. and Xcode Life.